AntineoplasticsLack of efficacy and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30285-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：144 / 144

相关论文

共 50 条

[21] AntineoplasticsLack off efficacy: case report
Reactions Weekly, 2020, 1831 (1) : 48 - 48
[22] AntineoplasticsLack of efficacy, and hand-foot syndrome following off-label use: case report
Reactions Weekly, 2022, 1927 (1) : 65 - 65
[23] AntineoplasticsLack of efficacy followed by off-label use: 2 case reports
Reactions Weekly, 2023, 1956 (1) : 64 - 64
[24] AntineoplasticsLack of efficacy, medication error and off label use: 3 case reports
Reactions Weekly, 2023, 1985 (1) : 65 - 65
[25] AntihypertensivesLack of efficacy and off label use : case report
Reactions Weekly, 2021, 1871 (1) : 47 - 47
[26] PaclitaxelLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1879 (1) : 306 - 306
[27] SulindacLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1964 (1) : 384 - 384
[28] DexamethasoneLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1933 (1) : 177 - 177
[29] DexamethasoneLack of efficacy and off label use: case report
Reactions Weekly, 2025, 2054 (1) : 144 - 144
[30] AntidepressantsLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1919 (1) : 53 - 53

← 1 2 3 4 5 →